m+Medelevator.RU
← Поиск публикаций
Contemporary clinical trials · 2026

Primary results from the targeted exercise for African-Americans with multiple sclerosis project.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Motl Robert W, Neal Whitney N, Pekmezi Dorothy, Flores Victoria, Kinnett-Hopkins Dominique

Аннотация

BACKGROUND: We undertook a randomized controlled trial (RCT) that examined the effects of a remotely-delivered, culturally-tailored exercise training (ET) program on immediate and sustained improvements in patient-reported outcome measures (PROMs) of walking dysfunction, symptoms, and health-related quality of life (HRQOL) among African-Americans with multiple sclerosis (MS).

METHODS: The study involved a parallel-group, RCT design, and enrolled 123 participants who were randomly assigned into remotely-delivered, culturally-tailored ET (Intervention; n = 63) or stretching and flexibility (Control; n = 60) conditions. The conditions were administered over 4-months by a behavioral coach uninvolved in screening, recruitment, random assignment, or outcome collection. We collected PROMs every 4 months over an 8-month period (baseline, immediate follow-up, 4-month follow-up). The primary PROM was walking dysfunction measured by the 12-item Multiple Sclerosis Walking Scale (MSWS-12).

RESULTS: The linear mixed model did not identify a statistically significant interaction between condition and time on MSWS-12 (p = .40). There was a statistically significant time effect on MSWS-12 (p < .005). This coincided with immediate and sustained reductions in MSWS-12 scores compared with baseline for both the Intervention and Control conditions that exceeded the established MCID of 8 points.

CONCLUSION: Our results provide preliminary evidence for the efficacy of two ET approaches for improving walking dysfunction in African-Americans with MS.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты